-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
All traditional Chinese medicine formula granule production enterprises: In order to strengthen the standardization of medical security and accelerate the formation of a unified national medical security information business coding standard, according to the "Notice of the National Medical Security Administration on Printing and Distributing the Guiding Opinions on the Standardization of Medical Security" (Medical Insurance [2019] 39 No.
) related requirements, our bureau decided to organize and carry out information maintenance of traditional Chinese medicine formula granules
.
The relevant matters are hereby notified as follows: 1.
Maintenance objects Manufacturers of traditional Chinese medicine formula granules
.
2.
Maintenance of varieties: Obtained the Chinese medicine formula granules with the listing/inter-provincial sales record number of the drug supervision and administration department
.
3.
Maintenance process All manufacturers of traditional Chinese medicine formula granules can log in to the "Dynamic Maintenance of Medical Insurance Business Coding Standards" window on the official website of the National Medical Security Administration (https://code.
nhsa.
gov.
cn/) to maintain product information
.
After the relevant information is reviewed and approved, it will be included in the national medical insurance information business coding standard database for use by local medical security departments
.
For specific maintenance methods, please refer to the operation guide
.
4.
Maintenance requirements (1) When the product information of traditional Chinese medicine formula granules obtained by the drug regulatory department for the listing/inter-provincial sales record number is added, deleted or changed, it should be maintained in time through the "Dynamic Maintenance of Medical Insurance Business Coding Standards" window
.
(2) For the traditional Chinese medicine formula granules that have obtained the registration number of the drug regulatory department for listing/inter-provincial sales before July 31, 2022 (inclusive), the relevant product information maintenance work should be completed before October 31, 2022
.
(3) Each manufacturer of traditional Chinese medicine formula granules should designate a special person to be responsible for the reporting and maintenance of the product information of the enterprise
.
Enterprises should ensure the authenticity and validity of the submitted information, and actively cooperate with the audit experts in the audit and verification of the submitted content
.
For problems found in the maintenance process, you can give feedback through the following channels: 1.
"Feedback" column in the "Dynamic Maintenance of Medical Insurance Business Coding Standards" window
.
2.
Email: code@nhsa.
gov.
com.
cn
.
3.
Mailing address: No.
2-9, Yuetan North Street, Xicheng District, Beijing, Standard Group, Planning, Finance and Regulations Department , National Medical Security Administration (Postal Code: 100830) .
Picture Medical Insurance Traditional Chinese Medicine Formula Granules Classification and Code Database Maintenance Operation Guide.
pdf National Medical Insurance Administration Planning, Finance and Regulations Department August 30, 2022
All traditional Chinese medicine formula granule production enterprises: In order to strengthen the standardization of medical security and accelerate the formation of a unified national medical security information business coding standard, according to the "Notice of the National Medical Security Administration on Printing and Distributing the Guiding Opinions on the Standardization of Medical Security" (Medical Insurance [2019] 39 No.